🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
Development of an active second-line treatment option for metastatic breast...
Status
Unknown
Location
Multiple Locations
Start Date
2019-10-25
Trial ID
NCT04143906
Treatments Being Tested
The purpose of this study is to evaluate S1 capsule plus Cisplatin as adjuv...
Status
Unknown
Location
Jun Feng Liu
Start Date
2014-12
Trial ID
NCT02223611
Treatments Being Tested
This study is a randomized controlled, open-label, multicenter phase III cl...
Status
Recruiting
Location
Erwei Song
Start Date
2023-12-01
Trial ID
NCT06079983
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This randomized phase III trial studies chemotherapy and bevacizumab to see...
Status
Completed
Location
Northeast Alabama Regional Medical Center
Start Date
2007-07-19
Trial ID
NCT00324805
This is a Single arm, Simon's two stage pilot study in which patients with ...
Status
Recruiting
Location
University of Illinois Cancer Center
Start Date
2024-12-16
Trial ID
NCT06576635
Treatments Being Tested
Trastuzumab or Herceptin is an antibody directed against Her-2. Her-2 is a ...
Status
Terminated
Location
Multiple Locations
Start Date
2002-07
Trial ID
NCT00169104
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of anlotin...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2022-03-22
Trial ID
NCT05296577
Treatments Being Tested
The primary objective of this study is to assess and compare the efficacy a...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2019-05-08
Trial ID
NCT03901339
Treatments Being Tested